Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anti-Mullerian Hormone | 5 | 2020 | 43 | 1.630 |
Why?
|
| Ovary | 4 | 2020 | 369 | 1.260 |
Why?
|
| Polyps | 2 | 2021 | 43 | 0.870 |
Why?
|
| Hysteroscopy | 2 | 2021 | 13 | 0.860 |
Why?
|
| Ultrasonography | 5 | 2024 | 993 | 0.850 |
Why?
|
| Ovulation Induction | 1 | 2024 | 42 | 0.850 |
Why?
|
| Fertilization in Vitro | 1 | 2024 | 161 | 0.780 |
Why?
|
| Sodium Chloride | 1 | 2021 | 93 | 0.710 |
Why?
|
| Uterus | 2 | 2024 | 548 | 0.680 |
Why?
|
| Genes, BRCA2 | 1 | 2020 | 48 | 0.670 |
Why?
|
| Genes, BRCA1 | 1 | 2020 | 60 | 0.660 |
Why?
|
| Fallopian Tubes | 1 | 2020 | 76 | 0.640 |
Why?
|
| Heterografts | 1 | 2018 | 197 | 0.550 |
Why?
|
| Ovarian Follicle | 1 | 2018 | 124 | 0.540 |
Why?
|
| RNA, Messenger | 2 | 2020 | 2674 | 0.460 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2438 | 0.390 |
Why?
|
| Pregnancy Trimester, First | 3 | 2020 | 123 | 0.340 |
Why?
|
| Yolk Sac | 2 | 2020 | 20 | 0.320 |
Why?
|
| Abortion, Spontaneous | 2 | 2021 | 84 | 0.310 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2008 | 13 | 0.280 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 75 | 0.260 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 261 | 0.250 |
Why?
|
| Pregnancy | 7 | 2024 | 7566 | 0.250 |
Why?
|
| Pilot Projects | 5 | 2021 | 1450 | 0.240 |
Why?
|
| Bartter Syndrome | 1 | 2005 | 3 | 0.230 |
Why?
|
| Female | 16 | 2024 | 70712 | 0.220 |
Why?
|
| Embryo Transfer | 1 | 2024 | 56 | 0.210 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 637 | 0.210 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2020 | 1009 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1297 | 0.200 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 1014 | 0.190 |
Why?
|
| Apoptosis | 2 | 2020 | 1892 | 0.190 |
Why?
|
| Vitrification | 2 | 2019 | 5 | 0.180 |
Why?
|
| Endometrium | 2 | 2021 | 277 | 0.180 |
Why?
|
| Receptors, Peptide | 2 | 2020 | 54 | 0.180 |
Why?
|
| Insulins | 1 | 2021 | 19 | 0.180 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2020 | 106 | 0.170 |
Why?
|
| Peritoneal Cavity | 1 | 2020 | 20 | 0.170 |
Why?
|
| Suction | 1 | 2020 | 54 | 0.170 |
Why?
|
| Pressure | 1 | 2020 | 131 | 0.170 |
Why?
|
| Gestational Sac | 1 | 2020 | 2 | 0.160 |
Why?
|
| Adult | 8 | 2024 | 31568 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 552 | 0.160 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 1347 | 0.160 |
Why?
|
| Granulosa Cells | 1 | 2020 | 140 | 0.150 |
Why?
|
| Humans | 16 | 2024 | 132061 | 0.150 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 164 | 0.150 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 21 | 0.150 |
Why?
|
| Mice, Nude | 1 | 2020 | 752 | 0.150 |
Why?
|
| Analysis of Variance | 1 | 2020 | 1009 | 0.150 |
Why?
|
| Nanog Homeobox Protein | 1 | 2018 | 27 | 0.140 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2018 | 42 | 0.140 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 59 | 0.140 |
Why?
|
| Receptors, Pituitary Hormone | 1 | 2017 | 2 | 0.140 |
Why?
|
| Ovariectomy | 1 | 2018 | 169 | 0.140 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2018 | 193 | 0.140 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 271 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2020 | 6567 | 0.130 |
Why?
|
| Cohort Studies | 2 | 2024 | 5164 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2146 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2024 | 17419 | 0.120 |
Why?
|
| Estradiol | 1 | 2018 | 487 | 0.120 |
Why?
|
| Laparoscopy | 1 | 2020 | 523 | 0.110 |
Why?
|
| Logistic Models | 1 | 2020 | 1838 | 0.110 |
Why?
|
| Placenta | 1 | 2019 | 540 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 1017 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2020 | 2508 | 0.100 |
Why?
|
| Mice | 2 | 2020 | 18507 | 0.090 |
Why?
|
| Receptors, FSH | 2 | 2020 | 20 | 0.080 |
Why?
|
| Inhibins | 2 | 2020 | 86 | 0.070 |
Why?
|
| Animals | 2 | 2020 | 34882 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 1294 | 0.060 |
Why?
|
| Potassium | 1 | 2005 | 275 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2005 | 209 | 0.050 |
Why?
|
| Adolescent | 1 | 2020 | 20562 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2021 | 112 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 177 | 0.040 |
Why?
|
| Oocyte Retrieval | 1 | 2020 | 5 | 0.040 |
Why?
|
| Follicular Fluid | 1 | 2020 | 8 | 0.040 |
Why?
|
| Gestational Age | 1 | 2005 | 1224 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2020 | 138 | 0.040 |
Why?
|
| Nomograms | 1 | 2019 | 38 | 0.040 |
Why?
|
| Pregnancy, Multiple | 1 | 2019 | 48 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 449 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2019 | 141 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 708 | 0.040 |
Why?
|
| Counseling | 1 | 2020 | 236 | 0.040 |
Why?
|
| Receptors, LH | 1 | 2017 | 15 | 0.030 |
Why?
|
| Receptors, Somatomedin | 1 | 2017 | 24 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 728 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2021 | 679 | 0.030 |
Why?
|
| Premenopause | 1 | 2017 | 40 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 95 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 3091 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 5409 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2005 | 3736 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 3380 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 5009 | 0.020 |
Why?
|
PEREGRIN-ALVAREZ's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_